Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-12Digital Implementation Support to Achieve Uptake and Integration of Task-Shared Care for Schizophrenia in Primary Care in India
-
CLINICAL_TRIALS study record update · 2026-02-11The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-02-11A Multicenter, Randomized, Open-label, 2-arm, 2-period Crossover Trial to Investigate the Effects of Food on the Pharmacokinetics of a Single Dose of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-02-11Randomised Control Trial of Effectiveness of Exercise Alone and tDCS+Exercise on Cognitive Function Improvement in Patients With Treatment Resistant Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-02-10A Phase 3, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment in Subjects With Schizophrenia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-02-10"My Coach Connect": Pilot Under the Partnered Research Center for Quality Care, RHINO 2008-0132
-
CLINICAL_TRIALS study record update · 2026-02-10The Efficacy and Safety of Pyrroloquinoline Quinone add-on Treatment for Negative and Cognitive Symptoms in Chronic Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-02-10Effect of Tirzepatide on Alcohol Intake and Reward Processing in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder
-
CLINICAL_TRIALS study record update · 2026-02-10An Adaptive Two-part Randomized, Double Blind, Placebo-controlled Phase 2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of Emraclidine in Participants With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-02-09Evaluating the Effectiveness of Mindfulness-Based Therapy for SMI Implemented in a Community Mental Health Setting
-
CLINICAL_TRIALS study record update · 2026-02-09Memantine Augmentation of Targeted Cognitive Training in Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-02-09Exploring the Efficacy of Cognitive Behavioral Therapy for Chronic Pain in Veterans With Serious Mental Illness
-
CLINICAL_TRIALS study record update · 2026-02-09Multicentre Evaluation of Bucco-dental Health in Patients With Schizophrenia in Côte d'Or
-
CLINICAL_TRIALS study record update · 2026-02-09Neural Mechanisms of Anticholinergic Burden in Mid- to Late-Life Schizophrenia Spectrum
-
CLINICAL_TRIALS study record update · 2026-02-09Efficacy of a Dental Health Promotion Program in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-02-09A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dosed Phase II Clinical Study to Evaluate the Efficacy and Safety of LPM787000048 Maleate Extended-Release Tablets (LY03020) in Acutely Psychotic Adult Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-02-09Enhancing Prefrontal Oscillatory Activity and Working Memory Performance With Noninvasive Brain Stimulation in Early-course Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-02-06The Effectiveness and Efficacy of the Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective for Patients With Mental Health Disorders
-
CLINICAL_TRIALS study record update · 2026-02-06Comprehensive Treatment of Early Course Schizophrenia: A Nonrandomized Study of Long Acting Injectable Antipsychotic Medication Combined With Cognitive and Functional Skills Training
-
CLINICAL_TRIALS study record update · 2026-02-06Validation of Scale to Evaluate the Perception of Oral Health in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-02-06A Phase III Randomized, Double-blind, Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of Iclepertin Once Daily Over 26 Week Treatment Period in Patients With Schizophrenia (CONNEX-3)
-
CLINICAL_TRIALS study record update · 2026-02-06The Neuro-VR Study: A Pilot Study Investigating an Innovative Virtual Reality-based Intervention Employing Biofeedback to Increase Tolerability and Therapy Efficacy in Psychosis
-
CLINICAL_TRIALS study record update · 2026-02-06Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (Clozapine)
-
CLINICAL_TRIALS study record update · 2026-02-06A Randomized, Placebo-controlled, Double-blind Phase 2 Study to Assess the Efficacy, Safety, Tolerability, and Pharmacodynamics of SPG302 in Adult Participants Diagnosed With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-02-04Illness Management and Recovery (IMR) in Danish Community Mental Health Centres: Protocol of a Randomized, Assessor-blinded Multi-centre Clinical Trial of a Recovery-oriented Program for People With Schizophrenia or Bipolar Disorder